Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.
04/10/11Neuralstem shares jump over 13% on new stem cell patent
16/12/10Neuralstem Receives FDA Approval to Start Phase Ia Trial for Depression Drug
14/09/10Study Shows Neuralstem’s Stem Cells May Have Application To Treating Stroke
Recent Sector News
U.S. stocks edged lower on Wednesday after two disappointing economic reports, with the S&P 500 and the Nasdaq on track to break their six-day win streaks as investors await an earnings parade after the bell.
Major deal-making has rekindled interest in the recently inactive pharmaceutical industry, propelling shares in the world's biggest drug makers higher.
Supreme Pharmaceuticals (OTCBB:SPRWF)(CSE:SL) has acquired the option for a producing medical marijuana facility in the South Okanagan of British Columbia, with the option to expire 60 days after receiving notice that a conditional commercial production license under Health Canada's new regulations has been granted.
Unlike most pharmaceutical companies, Montreal-based IntelGenx (CVE:IGX) (OTCQX:IGXT) has no plans to develop new drugs, concentrating its efforts instead on using its three proprietary enhanced drug delivery technologies to develop new therapeutic entities (NTEs).
Davies, who has more than 25 years of experience in the pharmaceutical industry and helped secure the first US IND for synthetic Cannabidiol at Yale University, runs STI Pharma, which develops investigational products for a wide range of clinical research.
The legal cultivation of medical and adult use marijuana is a field set to bring prosperity to a great many people due to changes at the regulatory level combined with a groundswell of acceptance for the idea of use itself.
Investors interested in Neuralstem recently viewed
- Medical Australia Limited (ASX: MLA) Medical devices developed, manufactured and distributed in Australia.
- Nanobiotix (EURONEXT: NANO) .
- Cellmid (ASX: CDY) Cellmid is the world leader in Midkine Intellectual Property
- ReNeuron (AIM: RENE) Leading stem cell company targeting areas of significant unmet medical need
- Sphere Medical (AIM: SPHR) Raising the Standard of Critical Care